Wigs as a Health Expense: The Hair Prosthesis
Expenses incurred for the purchase of a wig required following a chemotherapy treatment or for socially debilitating conditions such as alopecia are deductible. A medical certificate issued by the hospital where the person is being treated or by the doctor treating the specific condition is required to support this claim. In this case, hair implants are considered a healthcare expense, as they correct aesthetic damage resulting from a condition and simultaneously provide support in a condition of serious psychological distress. Hair implants benefit from a 19% Irpef discount and a 4% VAT on the invoice, in addition to specific financial contributions provided by the Regions (currently only for chemotherapy treatments).
A wig is classified as a medical device, as defined by the Ministry of Labor, Health, and Social Policies (now the Ministry of Health). A medical device is any instrument or appliance intended by the manufacturer for use in humans for the purpose of alleviating disease or injury.
Therefore, a wig may fall under the category of medical prostheses if it is manufactured and marketed with the intended use as a medical device, as defined above, and must be CE-marked in accordance with Directive 93/42/EEC.
If the patient has an insurance policy, it is advisable to check with the insurer about coverage for medical prostheses, specifically for hair prostheses (which will require CE certification and a relevant medical certificate).
For chemotherapy treatments, regional contributions are available, and the patient can access these directly by providing their bank account details (IBAN), the invoice for the purchase of the hair prosthesis with CE certification, and the specific medical certificate for the prosthesis.